Caris Life Sciences to Present Research Supporting Clinical Utility of Caris Molecular Intelligence® at 2016 Genitourinary Cancers Symposium
IRVING, Tex., Jan. 7, 2016 – Caris Life Sciences®, a leading biotechnology company focused on fulfilling the promise of precision medicine, announces today that it will present four poster presentations at the 2016 Genitourinary Cancers Symposium from January 7-9, 2016 in San Francisco, Calif. Each of the four studies being presented utilizes Caris Molecular Intelligence®,
Read more →